1172 / 1816
Conclusions Pre-menopausal ER+ BC
Effectivity aromatase inhibitor + ovarian suppression not convincing
Trend worser overall survival
•Impact ovarian suppression + TAM vs TAM:
–Trend better DFS and OS
–Young age
–Higher risk (initial chemotherapy)
•Don’t forget large influence Qol:
–AR / OFS > TAM + OFS > TAM
19-9-2017